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Abstract 
The purpose of this thesis was to obtain new data about the 
development of the mouse embryo during preimplantation stages. The 
research was based on Dr. Clare Chatot's earlier experiments and 
data which indicated that glutamine is used as an energy substrate 
in preimplantation mouse embryos and that the enzyme glutaminase 
was present in all preimplantation stages. We hypothesized that 
the next step in the embryo's metabolism would be the utilization 
of the enzyme glutamate dehydrogenase to convert glutamate to a-
ketoglutarate. The experimental purpose was to detect this enzyme 
at the I-cell, 2-cell, a-cell and blastocyst stages of the embryo's 
development. The paper provides background information obtained 
from previous experiments which helped develop our hypothesis. 
Experiments were completed to test the hypothesis. Results 
provided control data suggesting that the peR reaction and RNA 
preparation were working efficiently. Finally, the paper discusses 
the results and the conclusions drawn from them. 
Introduction 
Preimplantation Embryo Development 
The embryonic development of the mouse is a complex series of 
events triggered after fertilization of the egg by the sperm when 
the pronuclei of both migrate to the center of the egg and unite. 
In the case of the mouse, preimplantation development of the embryo 
is slow allowing time for the uterine tissue to prepare for 
receiving the embryo. After 24 hours, the embryo is still at the 
two-cell stage. The four-cell stage is achieved after 36 hours, 
eight-cell stage is achieved after two days, and blastocyst is 
complete after four days. These slow divisions, without any 
increase in mass, continue as the embryo moves along the oviduct 
into the uterus until implantation 4.5 days after fertilization 
(Hogan, 1986). 
During pre implantation development many changes in the pattern 
of RNA and protein synthesis occur. These changes in patterns of 
protein synthesis are the result of several processes after 
fertilization. During the one to two-cell stage there is an 
increased turnover rate of some proteins made on stable maternal 
mRNAs (Howlett and Bolton 1985). Also there is sUbstantial 
evidence of posttranslational modification of proteins synthesized 
on either maternal or embryonic RNA. These modifications include 
phosphorylation, glycosylation, or proteolytic cleavage (Banner et 
al. 1987). studies have also shown that some maternal mRNAs are 
utilized or suppressed selectively. At the mid-two-cell stage 
degradation of specific maternal mRNAs carried over from the oocyte 
occur and synthesis of proteins from embryonic mRNAs begin. 
However, some maternally encoded proteins can persist beyond this 
stage (Hogan, 1986). 
At the eight-cell stage compaction begins. This is a calcium 
sensitive process where the blastomeres flatten and increase their 
contact with each other forming tight junctions. Blastomeres also 
develop distinct apical and basal membrane and cytoplasmic domains. 
During compaction, cellular changes occur that alter both the cells 
surface properties and the cytoskeleton. One surface change 
involves the cells increase in Ca++ dependent adhesiveness, which 
allows the cells to adhere to one another and to lectin-coated 
beads. Also lamellipodia-like cell processes spread over the cells 
to increase their adhesive surfaces. Regionalization of 
microvilli, lectin binding sites, and intracellular organelles 
allow the cells to express contact-induced cell polarization 
necessary for compaction. The cells during this time also 
establish gap junction-mediated intercellular communication between 
all other cells of the morula unit. Lastly the cells gradually 
develop apical, zonular tight junctions between outside cells to 
generate an impermeable outer epithelial layer (Hogan, 1986). 
After compaction is complete the embryo has entered the 
blastocyst stage of development. During this stage, fluid is 
transported from the embryonic cells to a central blastocoel. This 
occurs via a basally localized sodium-potassium ATPase pump. 
Energy Metabolism in Preimplantation Embryos 
For it to be possible for the 1-cell embryo to develop into a 
blastocyst energy metabolism must be utilized. One metabolic 
pathway that provides the energy necessary for growth and 
development is the Tricarboxylic acid (TCA) cycle. During early 
development of the embryo glutamine, glucose, pyruvate, and lactate 
are the energy substrates used by the TCA cycle to generate CO2 • 
Studies done in vitro and in vivo have shown that glutamine can be 
utilized as an energy substrate by all preimplantation stage 
embryos by oxidation to CO2 through the TCA cycle (Chatot et ale 
1990). The percentage of total [ 14C]glutamine utilized to generate 
CO2 in embryos grown in vivo ranged from 70% at the 2-cell stage to 
20% at the 8-cell and blastocyst stages. Studies of 
preimplantation mouse embryos in culture suggest that at the 8-cell 
stage the embryo increases its utilization of glucose as its energy 
substrate to free glutamine for other cellular functions. This is 
required due to the increase in cell numbers and the embryos' need 
for increased synthesis of nucleic acids and proteins. The 
presence of glutamine throughout the preimplantation culture period 
and the requirement for glucose after Day 3 of culture facilitated 
increased development of embryos to the blastocyst stage. These 
findings suggest that in vivo glutamine is utilized with lactate 
and pyruvate as an energy source up to the 8-cell stage when 
glucose becomes the primary energy source (Chatot et ale 1989-
1990) . 
Glutamine Regulation 
Glutamine requires much regulation during this time. 
Regulation of the amino acid glutamine is dependent upon glutamine 
synthetase and glutaminase in brain and liver (Nicklas, 1988). 
Glutamine synthetase replenishes glutamine as it is utilized in the 
"glutamine cycle" and glutaminase converts glutamine to glutamate 
depending on the balance required in the cell. In this process, 
glutamate and gamma-aminobutyric acid (GABA) levels are maintained 
by glutamine derived from the extracellular space which in turn can 
be replenished by synthesis in the glia by glutamine synthetase. 
Therefore glutamine is important in producing glutamate which is 
then utilized in the TeA cycle and other reactions. 
Glutamate 
Glutamate is a free amino acid that is involved in many 
regulatory functions. Physiological, pharmacological, and 
biochemical studies provide compelling evidence that glutamate is 
a major excitatory neurotransmitter. The amino acid can also be 
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Figure 1. Tricarboxylic Acid Cycle. 
further metabolized to gamma-aminobutyric acid (GABA), which works 
as an inhibitory neurotransmitter necessary for cellular regulation 
in the brain (Banner et al., 1987). Glutamate also serves as an 
intricate component to the TCA cycle (Figure 1). This nine step 
cycle begins with the condensation of the two-carbon acetyl group 
from acetyl CoA with the four-carbon molecule oxaloacetate to form 
the six-carbon molecule citrate. The enzymatically catalyzed 
reaction of steps 2 through 9 convert each molecule of citrate back 
to oxaloacetate for reuse. In this process each cycle loses two CO2 
molecules. Also in this process 4 pairs of electrons are removed 
from the carbon atom: three pairs are transferred ~9 j m~' •• YlgB 
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of NAD+ to form 3NADH + 3H+; the remaining pair is transferred to 
the acceptor FAD to form FADH2 • The regeneration of the molecule 
oxaloacetate is propelled by the malate shuttle in the last three 
reactions of the cycle (Darnell et al. 1990) (figure 2). Here the 
cytosolic NADH+ reduces the four-carbon oxaloacetate to malate. 
Malate crosses the inner membrane in exchange for a-ketoglutarate 
and reduces NAD+, forming NADH+ as well as oxaloacetate in the 
matrix. But matrix oxaloacetate is impermeable to the inner 
mitochondrial membrane and can not pass directly back to the 
cytosol. So matrix oxaloacetate is converted into the amino acid 
asparate, which crosses the inner mitochondrial membrane to the 
cytosol in exchange for glutamate. In the cytosol the asparate is 
reconverted to oxaloacetate, completing the cycle. To allow the 
cycle to proceed, a-ketoglutarate is converted to the amino acid 
glutamate in the cytosol and crosses to the matrix, where it is 
reconverted to a-ketoglutarate. This complex electron shuttle 
involving glutamate allows oxaloacetate to be regenerated for use 
in the TeA cycle. The shuttle also oxidizes the cytosolic NADH+ to 
NAD+, and reduces the matrix NAD+ to NADH+ simultaneously. This 
process allows NAD+ to be available for glycolysis, conversion of 
glucose to pyruvate in the cytosol. The NADH+ and H+ will also 
allow ATP to be synthesized (Darnell et al., 1990). Because of its 
varied and critical roles in cellular functions, it is essential 
that glutamate production and degradation be finely regulated. 
Glutamate can also be converted directly to a-ketoglutarate. 
One enzyme central to the metabolism of glutamate to a-
ketoglutarate is glutamate dehydrogenase [GDH; L-glutamate:NAD(P)+ 
oxidoreductase (deaminating) ; EC 1.4.1.3] • The hexameric 
structured enzyme is found in the mitochondrial matrix and is 
thought to be localized predominantly in astroglial cells in brain. 
It catalyzes the following reversible reaction: a-ketoglutarate + 
NH4 + NAD (P) H <-> Glu + H20 + NAD (P) + . Thus glutamate dehydrogenase 
along with certain ligands control the production and degradation 
of the amino acid glutamate. It is hypothesized that the ligands 
adhere to distinct but overlapping binding sites on the enzyme. 
The overlapping nature of these sites allows for the binding of 
some ligands and excludes the binding of others. This would 
explain the allosteric behavior of the enzyme in which the ligands 
either inhibit or activate its activity (Fisher et ale 1973). The 
coenzyme NADH+ at higher concentrations inhibits the activity of 
the enzyme by binding to a second noncatalytic binding site which 
has a low affinity for the coenzyme. Studies have also revealed 
that the amino acid glutamate enhances the binding of the coenzyme 
NADH+, but this high substrate inhibition by NADH+ can be abolished 
at high enzyme concentrations. The coenzyme GTP also operates as 
an inhibitor by promoting the binding of NADH+ to its inhibitory 
site. The extent of GTP inhibition depends on the concentrations 
of inorganic phosphate and magnesium ions, both of which decrease 
the binding of GTP to glutamate dehydrogenase. other inhibitors to 
the enzyme include GDP, inositol triphosphate, and inositol 
diphosphate. In contrast ADP acts as an activator. It decreases 
the affinity of the catalytic site for NAD(P) (H) thus activating 
the oxidation of glutamate. This coenzyme also has the ability to 
displace NADH+ from its inhibitory binding site in an apparently 
competitive manner. other activators of glutamate dehydrogenase 
include a number of monocarboxylic L-amino acids. Of these, 
leucine has been most extensively studied. It appears to behave in 
a similar enzyme-coenzyme interaction as ADP although the site to 
which it binds is distinct from that occupied by ADP (Tipton & 
Couee, 1988). 
A complete functional model on this mitochondrial enzyme which 
accounts for its complex allosteric regulation by the various 
ligands is still unclear. But its importance in regulation of 
embryo growth and development at the cellular level is recognized. 
For our experimental purposes, we are studying GDH expression at 
different stages of preimplantation mouse development. This will 
provide information about utilization of glutamate and glutamine at 
the different stages, and their role in embryonic metabolism. 
Materials and Methods 
RNA Isolation 
Total RNA from adult mouse brain tissue or mouse embryos at 
the 1-cell and blastocyst stage was isolated by the Acid-Guanidine-
Phenol-Chloroform method of Chomczynski and Sacchi (1987). Brain 
tissue (or embryo) was homogenized and thoroughly dissolved in 2ml 
(200~1 for embryos) of denaturing solution [4M guanidinium 
thiocyanate, 25mM sodium citrate pH 7.0, 0.5% sarcosyl, O.lM 2-
mercaptoethanol). In a corex tube, 0.2ml (20~1 for embryos) of 2M 
sodium acetate pH 4.0, 2.0ml (200~1 for embryos) of water-saturated 
phenol, and 0.4ml (40~1 for embryos) of chloroform:isoamylalcohol 
(49:1) were added sequentially to the tissue guanidine solution, 
inverting the corex tube after each addition. The tubes were held 
on ice for 15 minutes. This was centrifuged at 10,000g for 20 
minutes at 4°C to separate the RNA from the DNA and proteins. The 
isolated RNA in the aqueous phase was precipitated with 2ml (200~1 
for embryos) of isopropanol for 1 hour at -20°C and again 
centrifuged at 10, OOOg for 20 minutes at 4°C. The liquid was 
removed and the pellet was resuspended in O. 6ml of denaturing 
solution and transferred to a 1.5ml eppendorf tube. This was 
reprecipitated with 1 volume of isopropanol for 1 hour at -20°C and 
microfuged for 10 minutes at 4°C. The RNA pellet was washed with 
1ml of 75% EtOH. The RNA was dissolved in sterile tissue culture 
water (50-100~1) and 10~1 of the RNA was used to determine its 
concentration. This was calculated from optical density 
measurements made in triplicate at 260nm. Aliquots (1-2~1) of 
brain RNA were electrophoresed in 0.7% agarose gels in TBE and 
ethidium bromide to assess RNA integrity and purity {i.e. absence 
of DNA contamination}. 
RT-PCR 
The procedure for reverse transcription and PCR amplification 
was similar to published methods {Sambrook et al. 1989}. Two 
micrograms of RNA from mouse brain or RNA from 25 embryo 
equivalents were transferred to a 0.5ml eppendorf tube and 
stabilized with 1~1 of calf thymus-tRNA (5mg/ml). The tube was 
heated in a 70°C water bath for 5 minutes and cooled on ice. The 
following were added: reverse transcriptase buffer {6~1 of 5x 
stock: 250mM Tris-HCL,pH 8.3, 200mM KCL, 30mM MgCI2. BRL cat 
#8025SA}, 20mM dNTPs [3~1 of stock prepared as in Maniatis cloning 
manual, {Sambrook et al. 1989}, dissolved in 100-125j.£1 water, 
neutralized with 1N NaOH to 6.5-7.0], 3'antisense primer to a 
portion of the nucleotide sequence of the coding region of the 
human GDH cDNA clone reading 5' GGA AAG CAT GGT GGA ACT ATT CCC 3' 
(Banner et. al. 1987) (1~1), RNasin (1j.£1, Promega), H20 (1~1, 
sterile tissue culture water, Sigma), DTT (3~1 of O.lmM stock, 
BRL) , and Moloney murine leukemia virus reverse transcriptase 
(1.5~1, 200 units/j.£l, BRL cat #8025SA). Reactions were incubated 
for 1 hour at 37°C and then heated to 95°C for 5 minutes. After 
reverse transcription, BSA (0.5j.£1 of 100x stock, 10mg/ml, BioLabs), 
PCR buffer (5~1 of lOx stock, 100mM KCL, 200mM Tris-HCL pH 8.8, 
100mM (NH4) 2S04' 20mM MgS04, 1.0% Triton X-100), sterile tissue 
culture water (42~1), 5'sense primer to a portion of the nucleotide 
sequence of the coding region of the human GDH cDNA clone reading 
5' G GCA AAG CCT TAT GAA GGA AGC ATC 3' (Banner et. al. 1987) 
(1~1), and Vent polymerase (1~1, 1,000 U/ml, #254S BioLabs) were 
added. The mixture was overlayed with 50~1 of mineral oil and 
transferred to a Precision Scientific Genetics thermocycler for 60 
cycles of PCR. A negative control tube for both RT and PCR 
included all components except RNA or DNA. Each PCR cycle 
consisted of a denaturing step (95°C, 1 minute), an annealing step 
(42°C, 1 minute) and an elongation step (72°C, 1 minute). For the 
first cycle only, the duration of the denaturing step was 6 minutes 
and for the final cycle only, the length of the elongation step was 
9 minutes. After the 60 cycles were completed the tubes were 
cooled to 22°C for 4 minutes. Reactions were stored at 4°C until 
analysis by 2% agarose gel electrophoresis in TBE and ethidium 
bromide. 
Control PCR Reaction 
Linearizing GDH Plasmid 
GDH plasmid was cut with EcoRI into linear DNA for use as a 
control template for PCR reactions. The following were added 
together in a 0.5ml eppendorf tube: DNA plasmid (4~I, l~g GDH) , 
TE pH 7.6 (9.5~1 of 1x stock), EcoRI buffer (1.6~1 of lOx stock: 
500mM NaCI, 1000mM Tris-HCL, 50mM MgCl2 , .25% Triton x-100 pH 7.9), 
and EcoRI (1.0~1). The tube was put in a 37°C water bath for 1 hour 
to digest. After digestion was completed, 2M sodium acetate pH 4.0 
(1.6~1) and cold absolute EtOH (2 vol.) were added. The tube was 
placed in the -70°C freezer for 30 minutes. Digested DNA was 
pelleted in the microfuge for 5 minutes. The pellet is saved and 
dissolved in 75~1 of 1 x TE pH 7.6 to give a concentration of about 
20-30ng/~I. The cut GDH plasmid is stored at 4°C. To visually 
-------------------------------------
check the results of the digestion, electrophoresis in a 0.7% 
nondenaturing agarose gel with Tris-Borate-EDTA running buffer 
containing ethidium bromide was used. 
PCR 
The procedure for PCR amplification was performed as a 
control for the RT-PCR experiments. The following were added to 
1J,LI of cut GDH plasmid: o. 5J,LI of BSA (100x stock, 10mg /ml, 
BioLabs), 5.0J,LI of PCR buffer (lOx stock, 100mM KCL, 200mM Tris-HCL 
pH 8.8, 100mM (NH4) 2S04' 20mM MgS04, 1. 0% Triton X-100), 1. 5J,LI of 
20mM dNTPs, 1.0J,LI of 5'sense GDH primer, 1.0J,LI of 3'antisense GDH 
primer, 42J,LI of sterile tissue culture water, 1.0J,LI of vent 
polymerase. The mixture was then overlayed with 50J,LI of mineral 
oil and placed in the Precision Scientific Genetic thermocycler for 
60 cycles as described for the reverse transcribed RNA samples. 
Results 
In this investigation we examined the GDH expression in mouse 
brain which is encoded on RNA. Therefore, RNA needed to be 
extracted and isolated from mouse brain. This was accomplished by 
the Acid-Guanidine-Phenol-Chloroform method of Chomczynski and 
Sacchi (1987) described in methods. To assess the integrity and 
purity of RNA, aliquots (1-2~g) of brain RNA were electrophoresed 
in a 0.7% agarose gel in TBE and ethidium bromide. If DNA was 
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Figure 3. Agarose electrophoresis gel of mouse brain RNA isolated 
by the Acid-Guanidine-Phenol-Chloroform method. Lane 1 shows the 
bands of the standard used for markers. Lane 2 is isolated mouse 
brain RNA, 18S, 28S and 5S rRNA bands are indicated. 
present, it could be detected as a orange fluorescent band at the 
well of the gel. The RNA appeared as 18S and 28S rRNA bands, a 
combined 5S rRNA and 4S tRNA band, and an mRNA smear between 18S 
and at least 28S or larger (Figure 3, lane 2). 
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Figure 4. Agarose electrophoresis gel of linearized GOH plasmid 
and the amplified portion of the linearized GOH plasmid by peR. 
Lane 1 contains Bst NI digested pBR322 standards which are used 
for markers. Lane 2 contains peR reaction products to which no 
DNA was added (negative control). Lane 3 contains the peR 
amplified fragment of the linearized GDH plasmid, approximately 
369 base pairs in length. Lane 4 contains the whole linearized 
GOH plasmid, approximately 4500 base pairs in length. 
In order to provide a positive control template for the peR 
the GDH (pYN751) plasmid was cut with EcoRI into linear DNA. To 
assess the success of the digestion the cut GDH plasmid was 
electrophoresed in a 0.7% agarose gel in TBE and ethidium bromide. 
The cut GDH DNA was detected as a orange fluorescent band of 
approximately 4500 base pairs (Figure 4, lane 4). 
This cut GDH plasmid was first used to test the PCR reaction 
to show that the solutions, dNTPs, primers, and Vent polymerase 
were working and not contaminated with GDH sequences. For this 
experiment two samples were prepared, one without cut GDH and the 
other with cut GDH (l-2~g). These samples were both amplified with 
a 3' antisense and a 5' sense primer for a portion of the coding 
region of the human GDH cDNA clone. The product is expected to 
contain a portion of the DNA sequence for GDH approximately 369 
base pairs long. The results are shown in figure 4 lanes 2 and 3. 
The control (lane 2) shows no GDH specific 369bp band indicating no 
contamination of solutions, while the plasmid (lane 3) produced the 
369bp band as expected. Figure 4 also shows the primers. They 
appear as low molecular weight bands at the bottom of the gel 
indicating that they are not forming primer dimers. 
To detect the GDH message in isolated mouse brain RNA we used 
RT-PCR. This technique involves reverse-transcribing RNA and then 
amplifying RNA-DNA hybrids by PCR. We expected that if we were to 
reverse-transcribe total RNA with a 3' antisense primer for a 
portion of the coding region of the human GDH cDNA clone, and then 
amplified with a 5'sense primer for the same, the product should 
contain a portion of the RNA sequence for GDH approximately 369 
base pairs long. Unfortunately, analysis by 2.0% agarose gel 
electrophoresis in TBE and ethidium bromide showed no trace of the 
appropriate sequence (Data not shown). 
To see whether the problem occurred in the RT or peR portion 
of the procedure, two samples of cut GDH DNA were amplified by peR. 
Both samples contained the same 3' antisense primer and 5' sense 
primer, dNTPs and Vent polymerase, but had different peR buffers 
(one from BRL and one prepared in the laboratory). Analysis of 
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Figure S. Agarose electrophoresis gel of the amplification of 
linear GDH plasmid DNA by peR. Lane 1 contains the pBR322 Bst 
NI standards. Lane 2 contains the control to detect contamination 
of peR solutions. Lane 3 contains the amplified portion of the 
linear GDH DNA (peR buffer prepared in the laboratory). Lane 4 
contains the amplified portion of the linear GDH DNA (peR buffer 
from BRL). 
cDNA products by 2.0% agarose gel electrophoresis showed the PCR 
amplification procedure to be running successfully, resulting in an 
orange fluorescent band of approximately 369 base pairs under both 
buffer conditions (Figure 5, lanes 3 and 4). GDH plamid (-) 
control again showed no 369bp band suggesting no contamination of 
solutions (Figure 5, lane 2). 
Since the PCR portion of the reaction has been consistently 
successful, the problem must lie with the RT portion of the 
procedure. To remedy the problem a number of ideas were tried. 
New reverse-transcriptase and 5x buffer were ordered, water and 
solutions were re-autoclaved, and newer RNasin (to prevent RNA 
breakdown prior to RT) and dNTPs were used. RT-PCR following each 
of these changes was still unsuccessful (data not shown). 
Discussion 
From these experiments we have drawn several conclusions. The 
PCR method used on the linearized GDH plasmid yielded the expected 
369 base pair fragment. But the RT-PCR was unsuccessful. This was 
most likely due to the sensitivity of the reverse transcriptase to 
heavy metals and contaminants still present in our water supply 
even following deionization and Milli Q purification. other 
laboratories have required additional charcoal filtration for some 
molecular reactions to work properly. This will be implemented in 
future experiments. 
If these experiments, RT-PCR using fragment GDH coding 
primers, were used on embryo RNA at the 1-cell, 2-cell, 8-cell, and 
blastocyst stages we would expect to find GDH expression at all 
stages. The original proposal involved studying GDH RNA expression 
in mouse embryos at the 1-cell, 2-cell, 8-cell, and blastocyst 
stages. We hypothesized that RT-PCR specific for GDH using 
preimplantation embryos should show expression at all stages. This 
is based on studies of glutamine which shows that it is used as an 
energy substrate at all stages (Chatot et al. 1990). Glutaminase, 
the enzyme which converts glutamine to glutamate is also present to 
varying degrees at all stages (Chatot et al., manuscript in 
preparation). Most probably the next step in glutamine utilization 
in the TCA cycle involves GDH conversion of glutamate to a-
ketoglutarate. since GDH indirectly regulates the acti vi ty of 
glutaminase by the degradation and synthesis of glutamate, it would 
be expected to also be found at each stage, perhaps at varying 
amounts. 
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